Genus
Mark Birri serves as the Global Head of Corporate Development & Strategy at Genus PLC since November 2014, focusing on group M&A, strategy, transformation, and leading aquaculture initiatives. Prior roles include Corporate Development & Strategy Director at ABS Global, where responsibilities included M&A and new project integration, and Strategy & Business Development Director at Genus plc, emphasizing group strategy and investor relations. Mark has also contributed as a Non Executive Board Member at Xelect Ltd and as a Non Executive Board Observer at Renovate Biosciences. Earlier experience includes equity capital markets roles at BankMuscat and advisory roles at Alantra and PwC. Mark holds qualifications from The Chartered Institute for Securities & Investment, ICAEW, and a degree in Economics from the University of Warwick.
This person is not in any teams
Genus
1 followers
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company's segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe. The Genus ABS segment is engaged in bovine sales business, excluding Asia, and serves dairy and beef customers in North America, Latin America and Europe. The Genus Asia segment is engaged in porcine and bovine business in Asia, and serves porcine, dairy and beef customers in Asian markets. In the porcine market, it sells boars and sows. In the dairy and beef markets, its primary product is bull semen. The Company offers embryos through its subsidiary, In Vitro Brasil S.A. Its porcine business has a network of over 600 breeding herds in approximately 40 countries.